Biographical Sketch
Sucheta Kulkarni, PhD, is a Project Staff in the Department of Clinical Pathology at the Cleveland Clinic Main Campus. Dr. Kulkarni came to Cleveland Clinic in 1992 as a fellow in the Department of Experimental Therapeutics. She subsequently did fellowships in the Departments of Cancer Biology and Molecular Cardiology before joining the Department of Clinical Pathology in 2005.
Dr. Kulkarni obtained her degree as a Bachelor of Science, A master of Science and a Master of Philosophy from the University of Poona in India. She subsequently earned the Doctorate degree in Life Sciences from the University of Bombay in India. Sh was a member of the faculty in the Department of Life Sciences at Sophia College, Mumbai, India before coming to Cleveland Clinic.
In 1997, Dr. Kulkarni was the First Runner-up for the Dr. F. Merlin Bumpus Junior Investigator Award, recognizing excellence in research by graduate students and postdoctoral fellows at the Cleveland Clinic. Her work was recognized and published in several articles in peer-reviewed journals. Some areas of her interests are Rho GTPases, cysteine protease calpain, cytoskeletal proteins, protein phosphatase, adhesion receptors and growth factor receptors.
Specialty Interests
regulation of adhesion and growth-induced transmission of signals in breast cancer by Calpain, role of calpain in mechanisms of resistance to anti-cancer therapies in HER2-positive breast cancer
Industry Relationships
Cleveland Clinic physicians and scientists report if they
have any collaborations with the pharmaceutical or medical
device industries as part of the Cleveland Clinic’s
procedures. The Cleveland Clinic publicly discloses
payments to its physicians and scientists for speaking and
consulting of $5,000 or more per year, and any equity,
royalties, and fiduciary relationships in companies with
which they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its doctors’
connections with industry and those of their immediate
family members. As of 9/4/2008,
Dr. Kulkarni has reported no financial relationship with
industry that is applicable to this listing. Patients
should feel free to contact their doctor about
relationships with industry and how the relationships are
overseen by the Cleveland Clinic. To learn more about
the Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to our
Integrity in Innovation page.
